Global Stem Cell Therapy Market: Focus on Treatment Type, Cell Source, Indication,11 Countries’ Data, and Competitive Landscape – Analysis and Forecast, 2019-2029
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Key Questions Answered in this Report:
The Global Stem Cell Therapy Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 27.99% during the forecast period, 2019-2029.
The global stem cell therapy market growth has been primarily attributed to the major drivers in this market such as increasing prevalence of chronic diseases, rising number of clinical trials for cell-based therapy, steady investment and consolidation in the regenerative medicine market, and favorable regulatory environment. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include product approvals, declining product price and increasing adoption rate. However, there are significant challenges which are restraining the market growth. High treatment cost, exorbitant cost required for set up, and ethical considerations related to the use of embryonic stem cells are the challenges faced by the market.
Expert Quote
“Adipose tissue has gained significant attention in the past few years, acting as a rich source of multipotent stem cells, owing to the ease and minimally invasive process of derivation of stem cells from adipose tissue .”
Scope of the Market Intelligence on Stem Cell Therapy Market
The stem cell therapy market research provides a holistic view of the stem cell therapy market in terms of various factors influencing it, including regulatory reforms, and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products allied with the therapeutic application of stem cells. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global stem cell therapy market.
Market Segmentation
The global stem cell therapy market is classified based on treatment type as allogenic and allogenic.
Based on the cell sources, the market is further segmented into five broad types i.e. bone marrow and peripheral blood, adipose tissue, umbilical cord and placenta, embryonic, and others.
Based on indication types, the market is further segmented into orthopaedic and dental, wounds and injuries, cardiology and neurology, immunology and inflammatory, oncology and metabolism, and others.
Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest-of-the-World.
Key Companies in the Global Stem Cell Therapy Industry
The key manufacturers who have been contributing significantly to the global stem therapy market include Athersys, Inc., CORESTEM, Inc, FUJIFILM Cellular Dynamics, JCR Pharmaceuticals Co., Ltd., Mesoblast Ltd, NuVasive, Inc., Orthofix Holdings, Inc., Osiris Therapeutics, Inc., Takeda Pharmaceutical Company Limited, U.S. Stem Cell, Inc., Vericel Corporation, AlloSource, ANTEROGEN.CO., LTD., Regenexx, and Reliance Life Sciences Private Limited, among others.
Key Questions Answered in this Report:
- What is the therapeutic potential of stem cells and what are the major application areas of stem cell therapy?
- What are the key trends of the global stem cell therapy market? How is the market evolving and what is its future scope?
- What are the major drivers, challenges, and opportunities of the global stem cell therapy market?
- What are the key developmental strategies implemented by the key players of the global stem cell therapy market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
- Which are the key companies offering stem cell therapy products and which are the other companies dealing in stem cell therapies and have their products in the pipeline?
- Which are the leading companies dominating the global stem cell therapy market? What was the market share of each of the key players of the global stem cell therapy market in 2018?
- What is the regulatory scenario of the global stem cell therapy market? What are the initiatives implemented by different governmental bodies to promote research involving stem cells?
- What was the market size of the global stem cell therapy market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global stem cell therapy market during the time period between 2019 and 2029?
- What are the different treatment types of stem cell therapy? Which treatment type dominates the market in 2018 and why? Which treatment type is expected to witness highest growth rate and to dominate in market in 2029?
- Which cell source type is leading the market in 2019 and which one is anticipated to witness massive rise in the demand in the forecast period between 2019?
- What are the potential indication areas of stem cell therapy? Which indication type is leading the market in 2018 and which indication type is anticipated to dominate the market in next 10 years? What are the different regulatory designations controlling stem cell therapy products and how are those affecting the growth of the global stem cell therapy market?
- What was the market value of the leading segments and sub-segments of the global stem cell therapy market? What are the different macro and micro factors influencing the growth of the market?
- How is the industry expected to evolve during the forecast period 2019-2029? How is each segment of the global stem cell therapy market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2029?
- Which region is expected to contribute the highest sales of the global stem cell therapy market during the time period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different stem cell therapy products? What are the leading countries of different regions that contribute significantly toward the growth of the stem cell therapy market?
- What are the key players of the global stem cell therapy market and what is their role in the market?
The Global Stem Cell Therapy Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 27.99% during the forecast period, 2019-2029.
The global stem cell therapy market growth has been primarily attributed to the major drivers in this market such as increasing prevalence of chronic diseases, rising number of clinical trials for cell-based therapy, steady investment and consolidation in the regenerative medicine market, and favorable regulatory environment. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include product approvals, declining product price and increasing adoption rate. However, there are significant challenges which are restraining the market growth. High treatment cost, exorbitant cost required for set up, and ethical considerations related to the use of embryonic stem cells are the challenges faced by the market.
Expert Quote
“Adipose tissue has gained significant attention in the past few years, acting as a rich source of multipotent stem cells, owing to the ease and minimally invasive process of derivation of stem cells from adipose tissue .”
Scope of the Market Intelligence on Stem Cell Therapy Market
The stem cell therapy market research provides a holistic view of the stem cell therapy market in terms of various factors influencing it, including regulatory reforms, and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products allied with the therapeutic application of stem cells. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global stem cell therapy market.
Market Segmentation
The global stem cell therapy market is classified based on treatment type as allogenic and allogenic.
Based on the cell sources, the market is further segmented into five broad types i.e. bone marrow and peripheral blood, adipose tissue, umbilical cord and placenta, embryonic, and others.
Based on indication types, the market is further segmented into orthopaedic and dental, wounds and injuries, cardiology and neurology, immunology and inflammatory, oncology and metabolism, and others.
Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest-of-the-World.
Key Companies in the Global Stem Cell Therapy Industry
The key manufacturers who have been contributing significantly to the global stem therapy market include Athersys, Inc., CORESTEM, Inc, FUJIFILM Cellular Dynamics, JCR Pharmaceuticals Co., Ltd., Mesoblast Ltd, NuVasive, Inc., Orthofix Holdings, Inc., Osiris Therapeutics, Inc., Takeda Pharmaceutical Company Limited, U.S. Stem Cell, Inc., Vericel Corporation, AlloSource, ANTEROGEN.CO., LTD., Regenexx, and Reliance Life Sciences Private Limited, among others.
Executive Summary
1 PRODUCT DEFINITION
2 SCOPE OF THE WORK
2.1 Overview: Report Scope
2.2 Segmentation of the Global Stem Cell Therapy Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report
2.5 Base Year and Forecast Period
3 RESEARCH METHODOLOGY
3.1 Overview: Report Methodology
4 GLOBAL STEM CELL THERAPY MARKET
4.1 Market Overview
4.2 Introduction of Stem Cell Therapy
4.3 Application of Stem Cells in Different Therapeutic Areas
4.4 Market Dynamics
4.5 Global Market Scenario
4.6 Assumptions and Limitations
5 COMPETITIVE LANDSCAPE
5.1 Overview
5.2 Key Developments and Strategies
5.2.1 Collaborations, and Partnerships
5.2.2 Approvals and Clinical Studies
5.2.3 Funding
5.2.4 Business Expansions
5.2.5 Product Launches and Developments
5.2.6 Mergers and Acquisitions
5.2.7 Others
5.3 Market Share Analysis
6 INDUSTRY INSIGHTS
6.1 Regulatory Scenario
6.2 Regulatory Designations
6.3 Expedited Designation Vs. Traditional Approval Timelines:
6.4 Regulatory Challenges:
7 GLOBAL STEM CELL THERAPY MARKET (BY TREATMENT TYPE)
7.1 Overview
7.2 Key Trends of the Global Stem Cell Therapy Market (by Treatment Type)
7.3 Autologous Treatment
7.4 Allogenic Treatment
8 GLOBAL STEM CELL THERAPY MARKET (BY CELL SOURCE)
8.1 Overview
8.2 Key Trends of the Global Stem Cell Therapy Market (by Cell Source)
8.3 Bone Marrow and Peripheral Blood
8.4 Adipose Tissue
8.5 Placenta and Umbilical Cord
8.6 Embryo
8.7 Others
9 GLOBAL STEM CELL THERAPY MARKET (BY INDICATION)
9.1 Overview
9.2 Key Trends of the Global Stem Cell Therapy Market (by Indication)
9.3 Orthopaedic and Dental
9.4 Wounds and Injuries
9.5 Cardiology and Neurology
9.6 Immunology and Inflammatory
9.7 Oncology and Metabolism
9.8 Others
10 GLOBAL STEM CELL THERAPY MARKET (BY REGION)
10.1 Overview
10.2 North America
10.2.1 Overview
10.2.2 U.S.
10.2.3 Canada
10.3 Europe
10.3.1 Overview
10.3.2 Germany
10.3.3 U.K.
10.3.4 France
10.3.5 Italy
10.3.6 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 Overview
10.4.2 Japan
10.4.3 Australia
10.4.4 China
10.4.5 South Korea
10.4.6 India
10.4.7 Rest-of-Asia-Pacific
10.5 Rest-of-the-World
10.5.1 Overview
10.5.2 Middle East and Africa
10.5.3 Latin America
11 COMPANY PROFILES
11.1 Overview
11.2 AlloSource
11.2.1 Company Overview
11.2.2 Role of AlloSource in the Global Stem Cell Therapy Market
11.2.3 SWOT Analysis
11.3 ANTEROGEN.CO., LTD.
11.3.1 Company Overview
11.3.2 Role of ANTEROGEN.CO., LTD. in the Global Stem Cell Therapy Market
11.3.3 SWOT Analysis
11.4 Athersys Inc.
11.4.1 Company Overview
11.4.2 Role of Athersys Inc. in the Global Stem Cell Therapy Market
11.4.3 SWOT Analysis
11.5 CORESTEM, Inc
11.5.1 Company Overview
11.5.2 Role of CORESTEM, Inc in the Global Stem Cell Therapy Market
11.5.3 Financials
11.5.4 SWOT Analysis
11.6 FUJIFILM Cellular Dynamics, Inc.
11.6.1 Company Overview
11.6.2 Role of FUJIFILM Cellular Dynamics, Inc. in the Global Stem Cell Therapy Market
11.6.3 Financials
11.6.4 SWOT Analysis
11.7 JCR Pharmaceuticals Co., Ltd.
11.7.1 Company Overview
11.7.2 Role of JCR Pharmaceuticals Co., Ltd. in the Global Stem Cell Therapy Market
11.7.3 Financials
11.7.4 SWOT Analysis
11.8 Mesoblast Ltd
11.8.1 Company Overview
11.8.2 Role of Mesoblast Ltd in the Global Stem Cell Therapy Market
11.8.3 Financials
11.8.4 SWOT Analysis
11.9 NuVasive, Inc.
11.9.1 Company Overview
11.9.2 Role of NuVasive, Inc. in the Global Stem Cell Therapy Market
11.9.3 Financials
11.9.4 SWOT Analysis
11.10 Orthofix Holdings, Inc.
11.10.1 Company Overview
11.10.2 Role of Orthofix Holdings, Inc. in the Global Stem Cell Therapy Market
11.10.3 Financials
11.10.4 SWOT Analysis
11.11 Osiris Therapeutics, Inc.
11.11.1 Company Overview
11.11.2 Role of Osiris Therapeutics, Inc. in the Global Stem Cell Therapy Market
11.11.3 Financials
11.11.4 SWOT Analysis
11.12 Regenexx
11.12.1 Company Overview
11.12.2 Role of Regenexx in the Global Stem Cell Therapy Market
11.12.3 SWOT Analysis
11.13 Reliance Life Sciences Private Limited
11.13.1 Company Overview
11.13.2 Role of Reliance Life Sciences Private Limited in the Global Stem Cell Therapy Market
11.13.3 SWOT Analysis
11.14 Takeda Pharmaceutical Company Limited
11.14.1 Company Overview
11.14.2 Role of Takeda Pharmaceutical Company Limited in the Global Stem Cell Therapy Market
11.14.3 Financials
11.14.4 SWOT Analysis
11.15 U.S. Stem Cell, Inc.
11.15.1 Company Overview
11.15.2 Role of U.S. Stem Cell, Inc. in the Global Stem Cell Therapy Market
11.15.3 SWOT Analysis
11.16 Vericel Corporation
11.16.1 Company Overview
11.16.2 Role of Vericel Corporation in the Global Stem Cell Therapy Market
11.16.3 Financials
11.16.4 SWOT Analysis
1 PRODUCT DEFINITION
2 SCOPE OF THE WORK
2.1 Overview: Report Scope
2.2 Segmentation of the Global Stem Cell Therapy Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report
2.5 Base Year and Forecast Period
3 RESEARCH METHODOLOGY
3.1 Overview: Report Methodology
4 GLOBAL STEM CELL THERAPY MARKET
4.1 Market Overview
4.2 Introduction of Stem Cell Therapy
4.3 Application of Stem Cells in Different Therapeutic Areas
4.4 Market Dynamics
4.5 Global Market Scenario
4.6 Assumptions and Limitations
5 COMPETITIVE LANDSCAPE
5.1 Overview
5.2 Key Developments and Strategies
5.2.1 Collaborations, and Partnerships
5.2.2 Approvals and Clinical Studies
5.2.3 Funding
5.2.4 Business Expansions
5.2.5 Product Launches and Developments
5.2.6 Mergers and Acquisitions
5.2.7 Others
5.3 Market Share Analysis
6 INDUSTRY INSIGHTS
6.1 Regulatory Scenario
6.2 Regulatory Designations
6.3 Expedited Designation Vs. Traditional Approval Timelines:
6.4 Regulatory Challenges:
7 GLOBAL STEM CELL THERAPY MARKET (BY TREATMENT TYPE)
7.1 Overview
7.2 Key Trends of the Global Stem Cell Therapy Market (by Treatment Type)
7.3 Autologous Treatment
7.4 Allogenic Treatment
8 GLOBAL STEM CELL THERAPY MARKET (BY CELL SOURCE)
8.1 Overview
8.2 Key Trends of the Global Stem Cell Therapy Market (by Cell Source)
8.3 Bone Marrow and Peripheral Blood
8.4 Adipose Tissue
8.5 Placenta and Umbilical Cord
8.6 Embryo
8.7 Others
9 GLOBAL STEM CELL THERAPY MARKET (BY INDICATION)
9.1 Overview
9.2 Key Trends of the Global Stem Cell Therapy Market (by Indication)
9.3 Orthopaedic and Dental
9.4 Wounds and Injuries
9.5 Cardiology and Neurology
9.6 Immunology and Inflammatory
9.7 Oncology and Metabolism
9.8 Others
10 GLOBAL STEM CELL THERAPY MARKET (BY REGION)
10.1 Overview
10.2 North America
10.2.1 Overview
10.2.2 U.S.
10.2.3 Canada
10.3 Europe
10.3.1 Overview
10.3.2 Germany
10.3.3 U.K.
10.3.4 France
10.3.5 Italy
10.3.6 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 Overview
10.4.2 Japan
10.4.3 Australia
10.4.4 China
10.4.5 South Korea
10.4.6 India
10.4.7 Rest-of-Asia-Pacific
10.5 Rest-of-the-World
10.5.1 Overview
10.5.2 Middle East and Africa
10.5.3 Latin America
11 COMPANY PROFILES
11.1 Overview
11.2 AlloSource
11.2.1 Company Overview
11.2.2 Role of AlloSource in the Global Stem Cell Therapy Market
11.2.3 SWOT Analysis
11.3 ANTEROGEN.CO., LTD.
11.3.1 Company Overview
11.3.2 Role of ANTEROGEN.CO., LTD. in the Global Stem Cell Therapy Market
11.3.3 SWOT Analysis
11.4 Athersys Inc.
11.4.1 Company Overview
11.4.2 Role of Athersys Inc. in the Global Stem Cell Therapy Market
11.4.3 SWOT Analysis
11.5 CORESTEM, Inc
11.5.1 Company Overview
11.5.2 Role of CORESTEM, Inc in the Global Stem Cell Therapy Market
11.5.3 Financials
11.5.4 SWOT Analysis
11.6 FUJIFILM Cellular Dynamics, Inc.
11.6.1 Company Overview
11.6.2 Role of FUJIFILM Cellular Dynamics, Inc. in the Global Stem Cell Therapy Market
11.6.3 Financials
11.6.4 SWOT Analysis
11.7 JCR Pharmaceuticals Co., Ltd.
11.7.1 Company Overview
11.7.2 Role of JCR Pharmaceuticals Co., Ltd. in the Global Stem Cell Therapy Market
11.7.3 Financials
11.7.4 SWOT Analysis
11.8 Mesoblast Ltd
11.8.1 Company Overview
11.8.2 Role of Mesoblast Ltd in the Global Stem Cell Therapy Market
11.8.3 Financials
11.8.4 SWOT Analysis
11.9 NuVasive, Inc.
11.9.1 Company Overview
11.9.2 Role of NuVasive, Inc. in the Global Stem Cell Therapy Market
11.9.3 Financials
11.9.4 SWOT Analysis
11.10 Orthofix Holdings, Inc.
11.10.1 Company Overview
11.10.2 Role of Orthofix Holdings, Inc. in the Global Stem Cell Therapy Market
11.10.3 Financials
11.10.4 SWOT Analysis
11.11 Osiris Therapeutics, Inc.
11.11.1 Company Overview
11.11.2 Role of Osiris Therapeutics, Inc. in the Global Stem Cell Therapy Market
11.11.3 Financials
11.11.4 SWOT Analysis
11.12 Regenexx
11.12.1 Company Overview
11.12.2 Role of Regenexx in the Global Stem Cell Therapy Market
11.12.3 SWOT Analysis
11.13 Reliance Life Sciences Private Limited
11.13.1 Company Overview
11.13.2 Role of Reliance Life Sciences Private Limited in the Global Stem Cell Therapy Market
11.13.3 SWOT Analysis
11.14 Takeda Pharmaceutical Company Limited
11.14.1 Company Overview
11.14.2 Role of Takeda Pharmaceutical Company Limited in the Global Stem Cell Therapy Market
11.14.3 Financials
11.14.4 SWOT Analysis
11.15 U.S. Stem Cell, Inc.
11.15.1 Company Overview
11.15.2 Role of U.S. Stem Cell, Inc. in the Global Stem Cell Therapy Market
11.15.3 SWOT Analysis
11.16 Vericel Corporation
11.16.1 Company Overview
11.16.2 Role of Vericel Corporation in the Global Stem Cell Therapy Market
11.16.3 Financials
11.16.4 SWOT Analysis
LIST OF TABLES
Table 1: Global Stem Cell Therapy Market, 2018 and 2029
Table 6.1: Regulatory Authorities/Associations/Consortiums of the Global Stem Cell Therapy Market
Table 7.1: Examples of Companies Offering Autologous Stem Cell Therapy Products
Table 7.2: Examples of Companies Offering Allogenic Stem Cell Therapy Products
Table 8.1: Examples of Companies Offering Stem Cell Therapy Products Derived from Bone Marrow and Peripheral Blood
Table 8.2: Examples of Companies Offering / Developing Stem Cell Therapy Products Derived from Adipose Tissue
Table 8.3: Examples of Companies Offering / Developing Stem Cell Therapy Products Derived from Either Placenta or Umbilical Cord
Table 8.4: Examples of Companies Developing Stem Cell Therapy Products Derived from Embryonic Stem Cells
Table 8.5: Examples of Companies Developing Stem Cell Therapy Products from Different Cell Sources
Table 9.1: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Orthopaedic and Dental
Table 9.2: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Wounds and Injuries
Table 9.3: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Cardiology and Neurology
Table 9.4: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Immunology and Inflammatory
Table 9.5: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Oncology and Metabolism
Table 9.6: Application of Stem Cells in Disease Therapeutics
Table 1: Global Stem Cell Therapy Market, 2018 and 2029
Table 6.1: Regulatory Authorities/Associations/Consortiums of the Global Stem Cell Therapy Market
Table 7.1: Examples of Companies Offering Autologous Stem Cell Therapy Products
Table 7.2: Examples of Companies Offering Allogenic Stem Cell Therapy Products
Table 8.1: Examples of Companies Offering Stem Cell Therapy Products Derived from Bone Marrow and Peripheral Blood
Table 8.2: Examples of Companies Offering / Developing Stem Cell Therapy Products Derived from Adipose Tissue
Table 8.3: Examples of Companies Offering / Developing Stem Cell Therapy Products Derived from Either Placenta or Umbilical Cord
Table 8.4: Examples of Companies Developing Stem Cell Therapy Products Derived from Embryonic Stem Cells
Table 8.5: Examples of Companies Developing Stem Cell Therapy Products from Different Cell Sources
Table 9.1: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Orthopaedic and Dental
Table 9.2: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Wounds and Injuries
Table 9.3: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Cardiology and Neurology
Table 9.4: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Immunology and Inflammatory
Table 9.5: Examples of Companies Offering Stem Cell Therapy Products Applied in the Field of Oncology and Metabolism
Table 9.6: Application of Stem Cells in Disease Therapeutics
LIST OF FIGURES
Figure 1: Global Stem Cell Therapy Market Segmentation, 2018 and 2029
Figure 2: Share of Key Developments and Strategies, January 2016-July 2019
Figure 3: Global Stem Cell Therapy Market Share (by Company), 2018
Figure 4: Global Stem Cell Therapy Market Share (by Treatment Type), 2018 and 2029
Figure 5: Global Stem Cell Therapy Market Share (by Cell Source), 2018 and 2029
Figure 6: Global Stem Cell Therapy Market Share (by Indication), 2018 and 2029
Figure 7: Global Stem Cell Therapy Market Share (by Region), 2017 and 2023
Figure 2.1: Global Stem Cell Therapy Market Segmentation
Figure 3.1: Global Stem Cell Therapy Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Bottom-up Approach (Segment-wise Analysis)
Figure 3.6: Top-Down Approach (Segment-wise Analysis)
Figure 3.7: Assumptions and Limitations
Figure 4.1: Drivers and Challenges of the Global Stem Cell Therapy Market
Figure 4.2: Global Stem Cell Therapy Market, 2018-2029
Figure 5.1: Competitive Landscape (January 2016-June 2019)
Figure 5.2: Share of Key Developments and Strategies, January 2016-July 2019
Figure 5.3: Collaborations, and Partnerships (by Company), January 2016 and June 2019
Figure 5.4: Approvals and Clinical Studies (by Company), January 2016 and June 2019
Figure 5.5: Fundings (by Company), January 2016 and June 2019
Figure 5.6: Business Expansions (by Company), January 2016 and June 2019
Figure 5.7: Product Launches and Developments (by Company), January 2016 and June 2019
Figure 5.8: Mergers and Acquisitions (by Company), January 2016 and June 2019
Figure 5.9: Market Share Analysis of Global Stem Cell Therapy Market, 2018
Figure 7.1: Stem Cells Therapy Market Segmentation (by Treatment Type)
Figure 7.2: Global Stem Cell Therapy Market (by Treatment Type), 2018-2029
Figure 7.3: Global Autologous Stem Cell Therapy Market, 2018-2029
Figure 7.4: Global Stem Cell Therapy Market, by Allogenic Treatment, 2018-2029
Figure 8.1: Stem Cells Therapy Market Segmentation (by Cell Source)
Figure 8.2: Global Stem Cell Therapy Market (by Cell Source), 2018-2029
Figure 8.3: Global Stem Cell Therapy Market (Bone Marrow and Peripheral Blood), 2018-2029
Figure 8.4: Global Stem Cell Therapy Market (Adipose Tissue), 2018-2029
Figure 8.5: Global Stem Cell Therapy Market (Umbilical Cord and Placenta), 2018-2029
Figure 8.6: Global Stem Cell Therapy Market (Embryo), 2018-2029
Figure 8.7: Global Stem Cell Therapy Market (Others), 2018-2029
Figure 9.1: Stem Cells Therapy Market Segmentation (by Indication)
Figure 9.2: Global Stem Cell Therapy Market (by Indication), 2018-2029
Figure 9.3: Global Stem Cell Therapy Market (Orthopaedic and Dental), 2018-2029
Figure 9.4: Global Stem Cell Therapy Market (Wounds and Injuries), 2018-2029
Figure 9.5: Global Stem Cell Therapy Market (Cardiology and Neurology), 2018-2029
Figure 9.6: Global Stem Cell Therapy Market (Immunology and Inflammatory), 2018-2029
Figure 9.7: Global Stem Cell Therapy Market (Oncology and Metabolism), 2018-2029
Figure 9.8: Global Stem Cell Therapy Market (Others), 2018-2029
Figure 10.1: Global Stem Cell Therapy Market (by Region), 2018-2029
Figure 10.2: North America: Stem Cell Therapy Market, 2018-2029
Figure 10.3: North America: Market Dynamics
Figure 10.4: North America: Stem Cell Therapy Market (by Country), 2018-2029
Figure 10.5: U.S.: Stem Cell Therapy Market, 2018-2029
Figure 10.6: Canada: Stem Cell Therapy Market, 2018-2029
Figure 10.7: Europe: Stem Cell Therapy Market, 2018-2029
Figure 10.8: Europe: Market Dynamics
Figure 10.9: Europe: Stem Cell Therapy Market (by Country), 2018-2029
Figure 10.10: Germany: Stem Cell Therapy Market, 2018-2029
Figure 10.11: U.K.: Stem Cell Therapy Market, 2018-2029
Figure 10.12: France: Stem Cell Therapy Market, 2018-2029
Figure 10.13: Italy: Stem Cell Therapy Market, 2018-2029
Figure 10.14: Rest-of-Europe: Stem Cell Therapy Market, 2018-2029
Figure 10.15: Asia-Pacific: Stem Cell Therapy Market, 2018-2029
Figure 10.16: Asia-Pacific: Market Dynamics
Figure 10.17: Asia-Pacific: Stem Cell Therapy Market (by Country), 2018-2029
Figure 10.18: Japan: Stem Cell Therapy Market, 2018-2029
Figure 10.19: Australia: Stem Cell Therapy Market, 2018-2029
Figure 10.20: China: Stem Cell Therapy Market, 2018-2029
Figure 10.21: South Korea: Stem Cell Therapy Market, 2018-2029
Figure 10.22: India: Stem Cell Therapy Market, 2018-2029
Figure 10.23: Rest-of-Asia-Pacific: Stem Cell Therapy Market, 2018-2029
Figure 10.24: Rest-of-the-World: Stem Cell Therapy Market, 2018-2029
Figure 10.25: Rest-of-the-World: Market Dynamics
Figure 10.26: Rest-of-the-World: Stem Cell Therapy Market (by Region), 2018-2029
Figure 10.27: Middle East and Africa: Stem Cell Therapy Market, 2018-2029
Figure 10.28: Latin America: Stem Cell Therapy Market, 2018-2029
Figure 11.1: Shares of Key Company Profiles
Figure 11.2: AlloSource: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.3: AlloSource: SWOT Analysis
Figure 11.4: ANTEROGEN.CO., LTD.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.5: ANTEROGEN.CO., LTD.: SWOT Analysis
Figure 11.6: Athersys Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.7: Athersys Inc.: SWOT Analysis
Figure 11.8: CORESTEM, Inc: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.9: CORESTEM, Inc: Overall Financials, 2016-2018
Figure 11.10: CORESTEM, Inc: R&D Expenditure (2016-2018)
Figure 11.11: CORESTEM, Inc: SWOT Analysis
Figure 11.12: FUJIFILM Cellular Dynamics, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.13: FUJIFILM Cellular Dynamics, Inc.: Overall Financials, 2016-2018
Figure 11.14: FUJIFILM Cellular Dynamics, Inc.: Revenue (by Business Segment), 2016-2018
Figure 11.15: FUJIFILM Cellular Dynamics, Inc.: Revenue (by Region), 2016-2018
Figure 11.16: FUJIFILM Cellular Dynamics, Inc.: R&D Expenditure (2016-2018)
Figure 11.17: FUJIFILM Cellular Dynamics, Inc.: SWOT Analysis
Figure 11.18: JCR Pharmaceuticals Co., Ltd.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.19: JCR Pharmaceuticals Co., Ltd.: Overall Financials, 2016-2018
Figure 11.20: JCR Pharmaceuticals Co., Ltd.: Revenue (by Segment), 2016-2018
Figure 11.21: JCR Pharmaceuticals Co., Ltd.: SWOT Analysis
Figure 11.22: Mesoblast Ltd: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.23: Mesoblast Ltd: Overall Financials, 2016-2018
Figure 11.24: Mesoblast Ltd: R&D Expenditure (2016-2018)
Figure 11.25: Mesoblast Ltd: SWOT Analysis
Figure 11.26: NuVasive, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.27: NuVasive, Inc.: Overall Financials, 2016-2018
Figure 11.28: NuVasive, Inc.: Revenue (by Segment), 2016-2018
Figure 11.29: NuVasive, Inc.: Revenue (by Region), 2016-2018
Figure 11.30: NuVasive, Inc.: R&D Expenditure (2016-2018)
Figure 11.31: NuVasive, Inc.: SWOT Analysis
Figure 11.32: Orthofix Holdings, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.33: Orthofix Holdings, Inc.: Overall Financials, 2016-2018
Figure 11.34: Orthofix Holdings, Inc.: Revenue (by Segment), 2016-2018
Figure 11.35: Orthofix Holdings, Inc.: Revenue (by Country), 2016-2018
Figure 11.36: Orthofix Holdings, Inc.: R&D Expenditure (2016-2018)
Figure 11.37: Orthofix Holdings, Inc.: SWOT Analysis
Figure 11.38: Osiris Therapeutics, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.39: Osiris Therapeutics, Inc.: Overall Financials, 2016-2018
Figure 11.40: Osiris Therapeutics, Inc.: Revenue (by Product), 2016-2018
Figure 11.41: Osiris Therapeutics, Inc.: R&D Expenditure (2016-2018)
Figure 11.42: Osiris Therapeutics, Inc.: SWOT Analysis
Figure 11.43: Regenexx: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.44: Regenexx: SWOT Analysis
Figure 11.45: Reliance Life Sciences Private Limited: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.46: Reliance Life Sciences Private Limited: SWOT Analysis
Figure 11.47: Takeda Pharmaceutical Company Limited: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.48: Takeda Pharmaceutical Company Limited: Overall Financials, 2016-2018
Figure 11.49: Takeda Pharmaceutical Company Limited: Revenue (by Region), 2016-2018
Figure 11.50: Takeda Pharmaceutical Company Limited: R&D Expenditure (2016-2018)
Figure 11.51: Takeda Pharmaceutical Company Limited: SWOT Analysis
Figure 11.52: U.S. Stem Cell, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.53: U.S. Stem Cell, Inc.: SWOT Analysis
Figure 11.54: Vericel Corporation: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.55: Vericel Corporation: Overall Financials, 2016-2018
Figure 11.56: Vericel Corporation: Revenue (by Product), 2016-2018
Figure 11.57: Vericel Corporation: R&D Expenditure (2016-2018)
Figure 11.58: Vericel Corporation: SWOT Analysis
Figure 1: Global Stem Cell Therapy Market Segmentation, 2018 and 2029
Figure 2: Share of Key Developments and Strategies, January 2016-July 2019
Figure 3: Global Stem Cell Therapy Market Share (by Company), 2018
Figure 4: Global Stem Cell Therapy Market Share (by Treatment Type), 2018 and 2029
Figure 5: Global Stem Cell Therapy Market Share (by Cell Source), 2018 and 2029
Figure 6: Global Stem Cell Therapy Market Share (by Indication), 2018 and 2029
Figure 7: Global Stem Cell Therapy Market Share (by Region), 2017 and 2023
Figure 2.1: Global Stem Cell Therapy Market Segmentation
Figure 3.1: Global Stem Cell Therapy Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Bottom-up Approach (Segment-wise Analysis)
Figure 3.6: Top-Down Approach (Segment-wise Analysis)
Figure 3.7: Assumptions and Limitations
Figure 4.1: Drivers and Challenges of the Global Stem Cell Therapy Market
Figure 4.2: Global Stem Cell Therapy Market, 2018-2029
Figure 5.1: Competitive Landscape (January 2016-June 2019)
Figure 5.2: Share of Key Developments and Strategies, January 2016-July 2019
Figure 5.3: Collaborations, and Partnerships (by Company), January 2016 and June 2019
Figure 5.4: Approvals and Clinical Studies (by Company), January 2016 and June 2019
Figure 5.5: Fundings (by Company), January 2016 and June 2019
Figure 5.6: Business Expansions (by Company), January 2016 and June 2019
Figure 5.7: Product Launches and Developments (by Company), January 2016 and June 2019
Figure 5.8: Mergers and Acquisitions (by Company), January 2016 and June 2019
Figure 5.9: Market Share Analysis of Global Stem Cell Therapy Market, 2018
Figure 7.1: Stem Cells Therapy Market Segmentation (by Treatment Type)
Figure 7.2: Global Stem Cell Therapy Market (by Treatment Type), 2018-2029
Figure 7.3: Global Autologous Stem Cell Therapy Market, 2018-2029
Figure 7.4: Global Stem Cell Therapy Market, by Allogenic Treatment, 2018-2029
Figure 8.1: Stem Cells Therapy Market Segmentation (by Cell Source)
Figure 8.2: Global Stem Cell Therapy Market (by Cell Source), 2018-2029
Figure 8.3: Global Stem Cell Therapy Market (Bone Marrow and Peripheral Blood), 2018-2029
Figure 8.4: Global Stem Cell Therapy Market (Adipose Tissue), 2018-2029
Figure 8.5: Global Stem Cell Therapy Market (Umbilical Cord and Placenta), 2018-2029
Figure 8.6: Global Stem Cell Therapy Market (Embryo), 2018-2029
Figure 8.7: Global Stem Cell Therapy Market (Others), 2018-2029
Figure 9.1: Stem Cells Therapy Market Segmentation (by Indication)
Figure 9.2: Global Stem Cell Therapy Market (by Indication), 2018-2029
Figure 9.3: Global Stem Cell Therapy Market (Orthopaedic and Dental), 2018-2029
Figure 9.4: Global Stem Cell Therapy Market (Wounds and Injuries), 2018-2029
Figure 9.5: Global Stem Cell Therapy Market (Cardiology and Neurology), 2018-2029
Figure 9.6: Global Stem Cell Therapy Market (Immunology and Inflammatory), 2018-2029
Figure 9.7: Global Stem Cell Therapy Market (Oncology and Metabolism), 2018-2029
Figure 9.8: Global Stem Cell Therapy Market (Others), 2018-2029
Figure 10.1: Global Stem Cell Therapy Market (by Region), 2018-2029
Figure 10.2: North America: Stem Cell Therapy Market, 2018-2029
Figure 10.3: North America: Market Dynamics
Figure 10.4: North America: Stem Cell Therapy Market (by Country), 2018-2029
Figure 10.5: U.S.: Stem Cell Therapy Market, 2018-2029
Figure 10.6: Canada: Stem Cell Therapy Market, 2018-2029
Figure 10.7: Europe: Stem Cell Therapy Market, 2018-2029
Figure 10.8: Europe: Market Dynamics
Figure 10.9: Europe: Stem Cell Therapy Market (by Country), 2018-2029
Figure 10.10: Germany: Stem Cell Therapy Market, 2018-2029
Figure 10.11: U.K.: Stem Cell Therapy Market, 2018-2029
Figure 10.12: France: Stem Cell Therapy Market, 2018-2029
Figure 10.13: Italy: Stem Cell Therapy Market, 2018-2029
Figure 10.14: Rest-of-Europe: Stem Cell Therapy Market, 2018-2029
Figure 10.15: Asia-Pacific: Stem Cell Therapy Market, 2018-2029
Figure 10.16: Asia-Pacific: Market Dynamics
Figure 10.17: Asia-Pacific: Stem Cell Therapy Market (by Country), 2018-2029
Figure 10.18: Japan: Stem Cell Therapy Market, 2018-2029
Figure 10.19: Australia: Stem Cell Therapy Market, 2018-2029
Figure 10.20: China: Stem Cell Therapy Market, 2018-2029
Figure 10.21: South Korea: Stem Cell Therapy Market, 2018-2029
Figure 10.22: India: Stem Cell Therapy Market, 2018-2029
Figure 10.23: Rest-of-Asia-Pacific: Stem Cell Therapy Market, 2018-2029
Figure 10.24: Rest-of-the-World: Stem Cell Therapy Market, 2018-2029
Figure 10.25: Rest-of-the-World: Market Dynamics
Figure 10.26: Rest-of-the-World: Stem Cell Therapy Market (by Region), 2018-2029
Figure 10.27: Middle East and Africa: Stem Cell Therapy Market, 2018-2029
Figure 10.28: Latin America: Stem Cell Therapy Market, 2018-2029
Figure 11.1: Shares of Key Company Profiles
Figure 11.2: AlloSource: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.3: AlloSource: SWOT Analysis
Figure 11.4: ANTEROGEN.CO., LTD.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.5: ANTEROGEN.CO., LTD.: SWOT Analysis
Figure 11.6: Athersys Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.7: Athersys Inc.: SWOT Analysis
Figure 11.8: CORESTEM, Inc: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.9: CORESTEM, Inc: Overall Financials, 2016-2018
Figure 11.10: CORESTEM, Inc: R&D Expenditure (2016-2018)
Figure 11.11: CORESTEM, Inc: SWOT Analysis
Figure 11.12: FUJIFILM Cellular Dynamics, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.13: FUJIFILM Cellular Dynamics, Inc.: Overall Financials, 2016-2018
Figure 11.14: FUJIFILM Cellular Dynamics, Inc.: Revenue (by Business Segment), 2016-2018
Figure 11.15: FUJIFILM Cellular Dynamics, Inc.: Revenue (by Region), 2016-2018
Figure 11.16: FUJIFILM Cellular Dynamics, Inc.: R&D Expenditure (2016-2018)
Figure 11.17: FUJIFILM Cellular Dynamics, Inc.: SWOT Analysis
Figure 11.18: JCR Pharmaceuticals Co., Ltd.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.19: JCR Pharmaceuticals Co., Ltd.: Overall Financials, 2016-2018
Figure 11.20: JCR Pharmaceuticals Co., Ltd.: Revenue (by Segment), 2016-2018
Figure 11.21: JCR Pharmaceuticals Co., Ltd.: SWOT Analysis
Figure 11.22: Mesoblast Ltd: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.23: Mesoblast Ltd: Overall Financials, 2016-2018
Figure 11.24: Mesoblast Ltd: R&D Expenditure (2016-2018)
Figure 11.25: Mesoblast Ltd: SWOT Analysis
Figure 11.26: NuVasive, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.27: NuVasive, Inc.: Overall Financials, 2016-2018
Figure 11.28: NuVasive, Inc.: Revenue (by Segment), 2016-2018
Figure 11.29: NuVasive, Inc.: Revenue (by Region), 2016-2018
Figure 11.30: NuVasive, Inc.: R&D Expenditure (2016-2018)
Figure 11.31: NuVasive, Inc.: SWOT Analysis
Figure 11.32: Orthofix Holdings, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.33: Orthofix Holdings, Inc.: Overall Financials, 2016-2018
Figure 11.34: Orthofix Holdings, Inc.: Revenue (by Segment), 2016-2018
Figure 11.35: Orthofix Holdings, Inc.: Revenue (by Country), 2016-2018
Figure 11.36: Orthofix Holdings, Inc.: R&D Expenditure (2016-2018)
Figure 11.37: Orthofix Holdings, Inc.: SWOT Analysis
Figure 11.38: Osiris Therapeutics, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.39: Osiris Therapeutics, Inc.: Overall Financials, 2016-2018
Figure 11.40: Osiris Therapeutics, Inc.: Revenue (by Product), 2016-2018
Figure 11.41: Osiris Therapeutics, Inc.: R&D Expenditure (2016-2018)
Figure 11.42: Osiris Therapeutics, Inc.: SWOT Analysis
Figure 11.43: Regenexx: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.44: Regenexx: SWOT Analysis
Figure 11.45: Reliance Life Sciences Private Limited: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.46: Reliance Life Sciences Private Limited: SWOT Analysis
Figure 11.47: Takeda Pharmaceutical Company Limited: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.48: Takeda Pharmaceutical Company Limited: Overall Financials, 2016-2018
Figure 11.49: Takeda Pharmaceutical Company Limited: Revenue (by Region), 2016-2018
Figure 11.50: Takeda Pharmaceutical Company Limited: R&D Expenditure (2016-2018)
Figure 11.51: Takeda Pharmaceutical Company Limited: SWOT Analysis
Figure 11.52: U.S. Stem Cell, Inc.: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.53: U.S. Stem Cell, Inc.: SWOT Analysis
Figure 11.54: Vericel Corporation: Product Portfolio for Global Stem Cell Therapy Market
Figure 11.55: Vericel Corporation: Overall Financials, 2016-2018
Figure 11.56: Vericel Corporation: Revenue (by Product), 2016-2018
Figure 11.57: Vericel Corporation: R&D Expenditure (2016-2018)
Figure 11.58: Vericel Corporation: SWOT Analysis
